An objective evaluation of eyedrop instillation in patients with glaucoma

Archives of Ophthalmology

Volumn 127, Issue 6, 2009, Pages 732-736

  Stone, Jennifer L ^a   Robin, Alan L ^b   Novack, Gary D ^c   Covert, David W ^d   Cagle, Gerald D ^d  

^a Glaucoma Specialists   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c PHARMALOGIC DEVELOPMENT INC   (United States)

^d ALCON RESEARCH LTD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIGLAUCOMA AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIMATOPROST; BRINZOLAMIDE; EYE DROPS; LATANOPROST; MUSCARINIC AGENT; POLYETHYLENE; POLYPROPYLENE; TRAVOPROST;

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED STUDY; DRUG INSTILLATION; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; TASK PERFORMANCE; VIDEORECORDING;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; DRUG PACKAGING; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES; QUESTIONNAIRES; TASK PERFORMANCE AND ANALYSIS; TONOMETRY, OCULAR; VIDEO RECORDING; YOUNG ADULT;

EID: 66949157203     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2009.96     Document Type: Article

References (22)

1. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):701-713, 829-830. (Pubitemid 34620348)
2. Lichter PR, Musch DC, Gillespie BW, et al; CIGTS Study Group. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108(11):1943-1953. (Pubitemid 33032760)
3. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS), 7: the relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;130(4):429-440.
4. Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol. 1998;126(4):498-505. (Pubitemid 28475913)
5. Kass MA, Meltzer DW, Gordon M, Cooper D, Goldberg J. Compliance with topical pilocarpine treatment. Am J Ophthalmol. 1986;101(5):515-523. (Pubitemid 16114195)
6. Kass MA, Gordon M, Morley RE Jr, Meltzer DW, Goldberg JJ. Compliance with topical timolol treatment. Am J Ophthalmol. 1987;103(2):188-193. (Pubitemid 17005483)
7. Robin AL, Novack GD, Covert DW, Crockett RS, Marcic TS. Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use. Am J Ophthalmol. 2007;144(4):533-540. (Pubitemid 47429615)
8. Norell SE, Granström PA. Self-medication with pilocarpine among outpatients in a glaucoma clinic. Br J Ophthalmol. 1980;64(2):137-141. (Pubitemid 10129630)
9. Friedman DS, Jampel HD, Congdon NG, Miller R, Quigley HA. The TRAVATAN Dosing Aid accurately records when drops are taken. Am J Ophthalmol. 2007;143(4):699-701. (Pubitemid 46452511)
10. Friedman DS, Quigley HA, Gelb L, et al. Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS). Invest Ophthalmol Vis Sci. 2007;48(11):5052-5057. (Pubitemid 351260915)
11. Schwartz GF, Reardon G, Mozaffari E. Persistency with latanoprost or timolol in primary open-angle glaucoma suspects. Am J Ophthalmol. 2004;137(1)(suppl):S13-S16. (Pubitemid 38091630)
12. Robin AL, Covert D. Does adjunctive glaucoma therapy affect adherence to the initial primary therapy? Ophthalmology. 2005;112(5):863-868. (Pubitemid 40631506)
13. Mercadante S, Fulfaro F. Alternatives to oral opioids for cancer pain. Oncology (Williston Park). 1999;13(2):215-220, 225. (Pubitemid 29102695)
14. Letocha CE. Methods for self-administration of eyedrops. Ann Ophthalmol. 1985;17(12):768-769. (Pubitemid 16178507)
15. Overaker RF, Dodge BC, Epstein DL. A new eyedrop dispensing bottle. Am J Ophthalmol. 1999;128(3):368-370. (Pubitemid 29413241)
16. Hodapp E, Parrish RK, Anderson DR. Clinical Decisions in Glaucoma. St Louis, MO: Mosby-Year Book Inc; 1993.
17. Brown MM, Brown GC, Spaeth GL. Improper topical self-administration of ocular medication among patients with glaucoma. Can J Ophthalmol. 1984;19(1):2-5. (Pubitemid 14159077)
18. Kass MA, Hodapp E, Gordon M, Kolker AE, Goldberg I. Patient administration of eyedrops, part II: observation. Ann Ophthalmol. 1982;14(9):889-893.
19. Kass MA, Hodapp E, Gordon M, Kolker AE, Goldberg I. Patient administration of eyedrops, part I: interview. Ann Ophthalmol. 1982;14(8):775-779. (Pubitemid 12047013)
20. Norell SE, Granstrom PA, Wassen R. A medication monitor and fluorescein technique designed to study medication behaviour. Acta Ophthalmol (Copenh). 1980;58(3):459-467. (Pubitemid 10082886)
21. Kholdebarin R, Campbell RJ, Jin Y-P, Buys YM. Multicenter study of compliance and drop administration in glaucoma. Can J Ophthalmol. 2008;43(4):454-461.
22. Tsai JC, McClure CA, Ramos SE, Schlundt DG, Pichert JW. Compliance barriers in glaucoma: a systematic classification. J Glaucoma. 2003;12(5):393-398. (Pubitemid 37237370)